CustomVue Mixed Astigmatism Approved by the FDA

VISX announced has received approval from the FDA to market and sell CustomVue treatments for mixed astigmatism. With this CustomVue approval, VISX leads the industry in wavefront-guided treatment for all forms of astigmatism, including nearsightedness with astigmatism, farsightedness with astigmatism and mixed astigmatism.

Forbes

(http://forbes.com/businesswire/feeds/businesswire/2005/03/21/businesswire20050321005369r1.html)